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Abstract 
Background: Obesity is a risk factor for cardiovascular disease, but metabolic disturbances can also lead to the devel‑
opment of this disease. Therefore, we investigated the associations between obesity subtype, considering both body 
weight and metabolic disturbances, and carotid atherosclerosis as a predictor of cardiovascular disease in Korean 
men.
Methods: Data from a total of 980 men were analysed in this study. Obesity subtypes were classified as normal 
weight without metabolic syndrome (metabolically healthy normal weight; MHNW), obesity without metabolic 
syndrome (metabolically healthy, but obese; MHO), normal weight with metabolic syndrome (metabolically abnor‑
mal, but normal weight; MANW) and obesity with metabolic syndrome (metabolically abnormal obese; MAO). Carotid 
intima‑media thickness (CIMT) and carotid plaque were assessed using a high‑resolution B‑mode ultrasound system. 
Carotid atherosclerosis was defined as a mean CIMT value >0.9 mm or the presence of carotid plaque.
Results: Mean CIMT in the MAO subtype was significantly higher than that in the MHNW control group 
(0.790 ± 0.019 vs. 0.747 ± 0.013 mm; p < 0.001). The presence of carotid plaque was positively associated with MAO 
subtype [adjusted odds ratio (aOR) 1.49, 95 % confidence interval (CI) 1.02–2.16; p = 0.039], but not with MHO or 
MANW, compared to the MHNW control group. The MAO subtype showed a positive association with the presence of 
carotid atherosclerosis (aOR 1.68, 95 % CI 1.17–2.42; p = 0.006).
Conclusions: Only the MAO subtype showed a higher CIMT value and positive associations with carotid plaque and 
carotid atherosclerosis, but not with MHO and MANW subtypes, compared to the MHNW control. Additional prospec‑
tive studies are needed to evaluate preclinical carotid atherosclerosis according to the subtypes of obesity.
Keywords: Obesity, Metabolic syndrome, Carotid atherosclerosis, Carotid plaque, Carotid intima‑media thickness
© 2015 Kim et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Obesity, which is defined as excess accumulation of body 
fat, is a major public health problem with a prevalence 
that is increasing worldwide [1]. Obesity is associated 
with an increased risk of cardiometabolic diseases, such 
as cardiovascular disease (CVD) and stroke. In addi-
tion, obesity-induced insulin resistance and metabolic 
abnormalities also cause cardiometabolic disease [2]. 
However, not all obese individuals show metabolic 
abnormalities, and not all normal-weight individuals 
show favourable metabolic conditions. Therefore, obe-
sity subtypes divided according to metabolic status such 
as metabolically healthy but obese (MHO), metaboli-
cally abnormal but normal weight (MANW), and meta-
bolically abnormal obese (MAO) have attracted attention 
[3, 4].
Several epidemiological studies have reported CVD/
stroke risks according to obesity subtypes, but the results 
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have been inconsistent. In a prospective cohort study, 
only MAO subtype showed increased rates of CVD/
stroke events compared to metabolically healthy normal 
weight (MHNW) [5], whereas CVD risks in MANW and 
MAO subtypes, which include participants with meta-
bolic disturbances regardless of body weight, were higher 
but, MHO subtype showed similar CVD risks than those 
in MHNW controls [6]. Furthermore, there have been 
few studies regarding the associations between obesity 
subtypes and CVD/stroke risk in Asia [7, 8].
Measurement of carotid intima-media thickness 
(CIMT) is a simple and non-invasive imaging tool for 
assessing structure and change in the carotid arterial 
wall. Increased CIMT is widely considered an indicator 
of atherosclerosis [9], and is linked to various adverse 
cardiovascular outcomes [10, 11]. Furthermore, carotid 
plaque is also associated with an increased risk of CVD/
stroke events [12, 13], and appears to be a more power-
ful predictor of CVD/stroke risk than CIMT alone [14]. 
Therefore, measurement of CIMT levels along with the 
assessment of carotid plaque is one of the important 
methods in the cardiovascular risk prediction. To date, 
however, few studies have addressed the association 
between the subtypes of obesity, CIMT levels, and carotid 
plaques [15–17]. Therefore, we investigated whether vari-
ous obesity subtypes are associated with CIMT values, 
the presence and severity of carotid plaques, and carotid 
atherosclerosis in Korean men.
Methods
Study population
The initial study population consisted of 1043 men who 
visited the health promotion centre of St. Vincent’s 
Hospital, Catholic University of Korea, Suwon, South 
Korea, for a health check-up between January 2011 and 
December 2014. We excluded subjects with a history of 
previous CVD/stroke events (n  =  33), or with thyroid 
disease (n  =  8), cancer (n  =  19), or decreased kidney 
function [estimated glomerular filtration rate (eGFR) 
<30  mL/min/1.73  m2; n  =  3]. In total, 980 men were 
included in the study. The study protocol was approved 
by the Catholic University of Korea, St. Vincent’s Hos-
pital, Institutional Review Board (IRB approval number: 
VC15RISI0072).
Classification of obesity
BMI level was classified as normal weight or obesity 
according to a BMI <25 kg/m2 and ≥25.0 kg/m2, respec-
tively [18]. The metabolically abnormal status was defined 
as having any three or more of the following, consistent 
with the revised National Cholesterol Education Program 
Adult Treatment Panel III (NCEP-ATP III) to define 
metabolic syndrome (MetS) [19]: waist circumference 
≥90  cm [20]; triglyceride level ≥150  mg/dL or taking 
medication for increased triglycerides; high-density lipo-
protein cholesterol (HDL-C) level <40  mg/dL or taking 
medication to improve HDL-C; systolic blood pressure 
≥130  mmHg or diastolic blood pressure ≥85  mmHg 
or taking anti-hypertensive agent; fasting glucose level 
≥100 mg/dL or taking blood glucose-lowering agent. The 
subtypes of obesity were divided into four groups based 
on the presence/absence of obesity and MetS: MHNW, 
MHO, MANW, and MAO.
Assessment of CIMT and carotid plaque
Assessment of the carotid arteries was measured with a 
high-resolution B-mode ultrasound system (ACUSON 
Antares; Siemens, Erlangen, Germany) with a linear 
9–13 MHz transducer, recorded by a single trained tech-
nician, and examined once per subject. CIMT, which is 
the distance between the luminal-intimal interface and 
the medial-adventitial interface, was measured by con-
ventional eye-measurement method at each of three lev-
els on the far walls of the right and left common carotid 
arteries, 1.5 cm proximal to the bifurcation, avoiding the 
sites of plaque. The average of maximal values of the right 
and left CIMT were used as a mean CIMT value. An 
increased mean CIMT was defined as mean CIMT value 
>0.9  mm [21]. For assessment of carotid plaque, the far 
and near walls of the right and left common carotid arter-
ies, bulbs, and internal carotid arteries were scanned. 
Carotid plaque, as a focal thickening encroaching into the 
lumen by 0.5 mm or by 50 % of the surrounding CIMT or 
where the intima-media thickness is ≥1.5 mm [21], was 
classified according to surface characteristics, echogenic-
ity, and texture. Surface characteristics were classified as 
smooth, mildly irregular (height variation in ≤0.4  mm), 
markedly irregular (height variation in >0.4  mm), or 
ulcerated (discrete depressions of >2  mm in width 
extending into the media). Echogenicity was character-
ised as hypoechoic, isoechoic, hyperechoic, or calcified. 
Texture was classified as homogeneous or heterogene-
ous. In cases with multiple focal lesions, the largest lesion 
was assessed. The severity of carotid plaque was clas-
sified as no plaque, moderate-risk plaque (remaining 
plaques, not including high-risk plaques), and high-risk 
plaque (the presence of markedly irregular or ulcerated 
surface, or hypo-echogenicity, or heterogeneous texture 
on plaques occupying >50 % of the total plaque volume). 
In the present study, carotid atherosclerosis was defined 
by the increased mean CIMT or the presence of carotid 
plaque [21].
Clinical and anthropometric measurements
Anthropometric measurements were obtained by 
specially trained examiners. Height and weight were 
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measured after an overnight fast while the participants 
wore a lightweight gown, and waist circumference was 
measured using a measuring tape in the horizontal plane 
around the umbilical region after exhaling. Blood pres-
sure measurements were taken in the sitting position 
after a rest period of at least 5 min. BMI was calculated 
as each participant’s weight in kilograms divided by the 
square of their height in meters.
Self-reported information regarding age, smoking, 
alcohol consumption, amount of physical activity, and 
medical histories were obtained. Subjects were divided 
into three categories based on current cigarette use esti-
mates: non-smoker, ex-smoker, or current smoker. Sub-
jects were divided into three categories based on alcohol 
consumption: abstinence (no alcoholic drinks consumed 
within the last year), moderate drinking (less than 14 
standard drinks consumed per week), and heavy drink-
ing (more than 14 standard drinks consumed per week). 
Low physical activity was defined as 150  min or less of 
moderate intensity or 75 min or less of vigorous intensity 
exercise per week. Past histories of hypertension, dys-
lipidemia, or diabetes mellitus were defined as a previous 
diagnosis with high blood pressure, dyslipidemia, or dia-
betes before this examination, and use of anti-hyperten-
sive, lipid, or blood glucose-lowering agents.
Laboratory measurements
Blood samples to measure biochemical parameters were 
collected from the antecubital vein of each participant 
after an overnight fast. Glucose, total cholesterol, tri-
glyceride, low-density lipoprotein cholesterol (LDL-C), 
HDL-C, and creatinine levels were determined using an 
auto-analyser (Hitachi 747; Hitachi, Tokyo, Japan), and 
fasting plasma insulin levels were determined by radio-
immunoassay (Immulite 2000 XPi system; Siemens, 
Erlangen, Germany). Insulin resistance was assessed 
using the homeostasis model assessment insulin resist-
ance (HOMA-IR) index, which was calculated as follows: 
[fasting glucose (mg/dL) × fasting insulin (μIU/mL)]/405 
[22]. The glomerular filtration rate was estimated by the 
re-expressed Modification of Diet in Renal Disease study 
equation using calibrated serum creatinine values [23]; 
the formula used for eGFR was as follows: 175 × (serum 
creatinine concentration)−1.154 × (age)−0.203.
Statistical analysis
The characteristics of the study participants were ana-
lysed by one-way analysis of variance for continuous vari-
ables and the Chi square test for dichotomous variables. 
The data are expressed as mean ± standard deviations or 
percentages and as medians with interquartile ranges for 
skewed distributions. The variables with skewed distri-
butions were analysed after logarithmic transformation. 
Correlation and regression coefficients between mean 
CIMT and associated risk factors were obtained by sim-
ple and multiple linear regression analyses. The differ-
ences in mean values of CIMT according to the subtypes 
of obesity were evaluated by analysis of covariance with 
age, smoking, alcohol consumption, physical activity, 
total cholesterol, LDL-C, HOMA-IR index, and eGFR 
levels as covariates. We also examined the relationships 
between the presence and severity of plaque, or the pres-
ence of carotid atherosclerosis as dependent variables 
and subtypes of obesity as the independent variables, 
using multiple logistic regression analysis. Model 1 was 
adjusted for age, model 2 was adjusted for age, smoking, 
alcohol consumption, and physical activity, and model 
3 was adjusted for age, smoking, alcohol consumption, 
physical activity, total cholesterol, LDL-C, HOMA-IR 
index, and eGFR levels. The percentages of participants 
with or without MetS regarding the presence/absence 
of obesity were analysed using the Chi square test. With 
regard to obesity, the associations between increased 
mean CIMT, the presence of carotid plaque or carotid 
atherosclerosis and the presence of MetS were examined 
by multiple logistic regression analysis adjusted using the 
abovementioned variables as covariates. The statistical 
analyses were performed using SPSS software for win-
dows (ver. 21.0, IBM Corp., Armonk, NY, USA). In all 
of the analyses, p < 0.05 was taken to indicate statistical 
significance.
Results
In a total of 980 men aged 19–80  years of age (mean 
age, 49.9 years), the prevalence rates of MHNW, MHO, 
MANW, and MAO types were 41.4, 24.6, 8.2, and 25.8 %, 
respectively. Significant differences in age, past medical 
history, waist circumference, systolic and diastolic blood 
pressures, fasting glucose, triglycerides, HDL-C, HOMA-
IR index, and eGFR levels as well as mean CIMT and the 
presence of carotid plaque were observed according to 
the subtypes of obesity (Table 1).
As shown in Table  2, significant correlations were 
observed between age, heavy drinking, past histories of 
diabetes or hypertension, BMI, LDL-C, HOMA-IR index, 
eGFR, the presence of MetS, and mean CIMT by simple 
regression analysis (p  <  0.05). Stepwise multiple regres-
sion analysis indicated that age, current smoking, diabe-
tes, BMI, and LDL-C values were positive independent 
determinants of mean CIMT (p  <  0.005), whereas the 
presence of MetS was not.
The mean CIMT values adjusted for covariates, such 
as age, smoking, alcohol consumption, physical activ-
ity, total cholesterol, LDL-C, HOMA-IR index, and 
eGFR levels according to subtypes of obesity are shown 
in Fig.  1. Mean CIMT increased according to group 
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in the order MHO, MANW, and MAO compared to 
MHNW controls (p for trend <0.001). Mean CIMT of 
MHNW control, MHO, MANW, and MAO subtypes 
were 0.747  ±  0.013, 0.752  ±  0.018, 0.757  ±  0.030, and 
0.790  ±  0.019  mm, respectively. Mean CIMT in MAO 
was significantly higher than that in the MHNW group 
(p < 0.001), but no differences in mean CIMT values were 
seen among the MHNW control, MHO and MANW 
subtypes.
After adjusting for age (model 1), the adjusted odds 
ratio (aOR) of the presence of carotid plaque in MAO was 
1.49 [95 % confidence interval (CI) 1.01–2.00; p = 0.043], 
and the presence of carotid plaque was still positively 
associated with MAO subtype after adjusting for age, 
smoking, alcohol consumption, and physical activ-
ity (model 2) (aOR 1.49, 95 % CI 1.03–2.16; p = 0.036). 
The positive association between MAO subtype and the 
presence of carotid plaque remained significant (aOR 
1.49, 95  % CI 1.02–2.16; p  =  0.039) after adjusting for 
age, smoking, alcohol consumption, physical activity, 
total cholesterol, LDL-cholesterol, HOMA-IR index, and 
eGFR levels (model 3). The presence of moderate-risk 
plaque was associated with MAO subtype after adjusting 
for age, smoking, alcohol consumption, physical activ-
ity (model 2) (aOR 1.65, 95 % CI 1.01–2.68, p = 0.046), 
and the association remained significant after adjusting 
for the abovementioned covariates (model 3) (aOR 1.87, 
95 % CI 1.11–3.14; p = 0.019), but the presence of high-
risk plaque was not associated with subtypes of obesity. 
No significant association was found between the pres-
ence or severity of carotid plaques and MHO or MANW 
subtypes (Table 3).
After adjusting for age, smoking, alcohol consumption, 
physical activity, past medical history, total cholesterol, 
LDL-C, HOMA-IR index, and eGFR levels, the aORs 
of carotid atherosclerosis in the MHO, MANW, and 
MAO subtypes were 1.18 (95 % CI 0.80–1.74; p = 0.294), 
1.01 (95  % CI 0.57–1.78; p =  0.575), and 1.68 (95  % CI 
1.17–2.42; p = 0.006), respectively, compared to MHNW 
controls; thus, only the MAO subtype was positively 
associated with the presence of carotid atherosclerosis 
(Fig. 2).
The percentage of metabolically abnormal men among 
the obese subjects was 51.2 %, whereas that among men 
with normal weight was 16.5  % (Fig.  3). Normal weight 
subjects showed no associations between increased 
Table 1 Characteristics of the study participants according to subtypes of obesity
CIMT carotid intima-media thickness, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, HDL-C high-density lipoprotein cholesterol, HOMA-IR 
homeostasis model assessment insulin resistance, LDL-C low-density lipoprotein cholesterol, MANW metabolically abnormal, but normal weight, MAO metabolically 
abnormal obese, MHO metabolically healthy, but obese, MHNW metabolically healthy normal weight, SBP systolic blood pressure
a Values are expressed as means ± standard deviation or percentages and as medians (interquartile ranges) for skewed distribution
All MHNW MHO MANW MAO p value
N (%) 980 (100.0) 406 (41.4) 241 (24.6) 80 (8.2) 253 (25.8) –
Age (years) 49.9 ± 10.8 49.8 ± 11.1 47.3 ± 10.7 55.2 ± 10.2 50.7 ± 9.9 <0.001
Current smoking (%) 36.1 36.2 37.2 28.2 37.2 0.378
Heavy drinking (%) 28.1 26.1 31.5 28.6 27.9 0.542
Low physical activity (%) 59.1 57.1 56.1 70.0 61.8 0.273
Diabetes mellitus (%) 11.6 7.2 4.2 31.3 19.4 <0.001
Hypertension (%) 24.5 13.8 16.3 43.8 43.1 <0.001
Dyslipidemia (%) 4.0 2.2 4.2 3.8 6.7 0.041
Fasting glucose (mg/dL)a 95 (88–105) 91 (85–98) 92 (87–98) 105 (100–139) 104 (94–119) <0.001
Total cholesterol (mg/dL)a 199 (174–223) 199 (176–223) 201 (176–226) 194 (178–221) 205 (172–231) 0.767
Triglycerides (mg/dL)a 130 (92–184) 102 (75–140) 113 (90–146) 183 (141–235) 177 (135–242) <0.001
HDL‑C (mg/dL)a 43 (37–47) 47 (42–55) 44 (40–49) 37 (34–42) 37 (34–44) <0.001
LDL‑C (mg/dL) 122.8 ± 32.1 123.1 ± 30.6 124.8 ± 32.8 121.2 ± 36.7 121.2 ± 32.3 0.613
HOMA‑IR indexa 0.84 (0.46–1.75) 0.51 (0.42–1.05) 0.86 (0.47–1.55) 1.29 (0.63–2.14) 1.59 (0.82–2.69) <0.001
eGFR (mL/min/1.73 m2) 92.3 ± 16.1 94.5 ± 14.3 91.7 ± 17.2 89.3 ± 17.4 90.2 ± 16.9 0.002
SBP (mmHg) 127.0 ± 12.8 123.2 ± 12.9 124.7 ± 12.4 134.0 ± 10.6 131.6 ± 11.5 <0.001
DBP (mmHg) 77.4 ± 9.5 75.1 ± 9.3 75.5 ± 9.5 81.9 ± 8.6 80.5 ± 9.0 <0.001
Waist circumference (cm) 88.0 ± 7.4 82.2 ± 5.1 91.2 ± 4.4 85.8 ± 4.1 95.1 ± 5.7 <0.001
Body mass index (kg/m2) 25.1 ± 2.9 22.6 ± 1.7 26.8 ± 1.7 23.5 ± 1.1 27.9 ± 2.2 <0.001
Mean CIMT (mm)a 0.75 (0.65–0.88) 0.72 (0.62–0.84) 0.72 (0.62–0.84) 0.77 (0.67–0.91) 0.80 (0.70–0.90) <0.001
Carotid plaque (%) 28.1 26.6 22.4 33.8 34.0 0.019
Carotid atherosclerosis (%) 38.7 36.0 33.2 46.3 45.8 0.008
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mean CIMT value, carotid plaque, carotid atheroscle-
rosis, and MetS. Among the obese subjects, aORs for 
increased CIMT, the presences of carotid plaque and 
atherosclerosis in metabolically abnormal men were 1.80 
(95 % CI 1.02–3.17; p = 0.041), 1.66 (95 % CI 1.02–2.67; 
p  =  0.039) and 1.69 (95  % CI 1.07–2.65; p  =  0.023), 
respectively, compared to metabolically healthy men 
(Table 4).
Discussion
We investigated the associations between CIMT, carotid 
plaque, carotid atherosclerosis and subtypes of obesity 
in Korean men. Mean CIMT in the MAO subtype was 
significantly higher than that in MHNW controls. The 
presence of carotid plaque was positively associated with 
MAO subtype, but not with MHO or MANW, compared 
to MHNW controls. Only the MAO subtype showed 
a positive association with the presence of carotid 
atherosclerosis.
The occurrence of clinical CVD/stroke events from the 
presence of the associated risk factors usually need for a 
long-term period [24]. The confirmation of subclinical 
atherosclerosis, such as abnormalities in left ventricular 
structure and function [25], coronary calcification [15], 
and increased CIMT [16] could better identify the influ-
ence of cardiovascular risk factors, such as obesity and 
metabolic abnormalities alone or in combination, within 
a shorter period than the estimation of overt CVD/stroke 
events [24, 26]. In this regard, the measurement of sub-
clinical carotid atherosclerosis is an appropriate predic-
tor for evaluating the risks of CVD/stroke before the 
occurrence of such events [11, 12, 27].
We measured not only mean CIMT, but also the pres-
ence and severity of carotid plaque for assessment of 
carotid atherosclerosis. As reported in several previous 
studies, the presence of carotid plaque was a stronger 
predictor of CVD/stroke events than the measurement 
of CIMT [14, 28]. Furthermore, carotid plaque provided 
a superior negative predictive value and likelihood ratio 
of a negative test than CIMT as well as coronary calcium 
score and C-reactive protein, which are other independ-
ent predictors of CVD events [29]. In this study, the pres-
ence of carotid plaque was positively associated with 
MAO subtype, but not with MHO and MANW sub-
types. Interestingly, however, the presence of high-risk 
or vulnerable carotid plaque was not associated with any 
subtype of obesity, but moderate-risk plaque showed a 
positive relationship with MAO subtype. These results 
may have been due to the close correlation of the features 
of high-risk plaque with previous CVD/stroke events 
[10]; subjects with a history of previous CVD/stroke 
events were excluded from this analysis.
In the present study, the MHO subtype did not show 
risks of carotid atherosclerosis. However, these results 
must be interpreted with caution. Because the partici-
pants with the MHO subtype were younger than those 
Table 2 Correlations between  carotid intima-media thick-
ness value and associated risk factors
Correlation coefficient (r) and regression coefficient (ß) were obtained by simple- 
and multiple linear regression analysis. Results in italics indicate statistical 
significance at the 0.05 level
CIMT carotid intima-media thickness, DBP diastolic blood pressure, eGFR 
estimated glomerular filtration rate, HOMA-IR homeostasis model assessment 
insulin resistance, LDL-C low-density lipoprotein cholesterol, SBP systolic blood 
pressure
a Variables with skewed distributions performed log-transformation
Correlations with CIMT value
r p value ß p value
Age (years) 0.555 <0.001 0.012 <0.001
Current smoking −0.003 0.933 0.025 0.004
Heavy drinking 0.087 0.007 – –
Low physical activity 0.015 0.648 – –
Diabetes mellitus 0.210 <0.001 0.097 <0.001
Hypertension 0.153 <0.001 – –
Dyslipidemia 0.044 0.168 – –
SBP (mmHg) 0.077 0.050 – –
DBP (mmHg) −0.006 0.887 – –
Body mass index (kg/m2) 0.088 0.006 0.011 <0.001
Total cholesterol (mg/dL)a 0.044 0.173 – –
LDL‑C (mg/dL) 0.083 0.010 0.001 <0.001
HOMA‑IR indexa 0.138 <0.001 – –
eGFR (mL/min/1.73 m2) −0.190 <0.001 – –























Fig. 1 Carotid intima‑media thickness according to obesity subtypes. 
Data are expressed as mean ± standard deviation. Only significant p 
values in CIMT differences among groups are presented. CIMT carotid 
intima‑media thickness, MHNW metabolically healthy normal weight, 
MHO metabolically healthy, but obese, MANW metabolically abnor‑
mal, but normal weight, MAO metabolically abnormal obese
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with the MAO subtype, the MHO subtype may transi-
tion from obese status without metabolic abnormalities 
to obese status with metabolic abnormalities for a long 
time, and the clinical outcomes including vascular change 
may manifest after long-term follow-up [5]. Indeed, in a 
previous prospective study, the subjects who maintained 
their baseline metabolic status after follow-up in MHO 
subtype showed similar developments of CVD compared 
to MHNW controls [5], suggesting that targeted inter-
vention may be needed to maintain favourable metabolic 
health in younger MHO subtype Koreans.
Several studies reported that the MANW subtype show 
increased rates of CVD/stroke events than MHNW con-
trols [6], whereas the results in other studies do not [5]. 
In fact, the phenotype of NAMW subtype could show 
Table 3 Odds ratios and 95 % confidence intervals for carotid plaque according to subtypes of obesity
Values are expressed as odds ratio (95 % confidence interval). Model 1 adjustment for age, Model 2 adjustment for Model 1 + smoking, alcohol consumption, physical 
activity, Model 3 Model 2 + total cholesterol, LDL-C, HOMA-IR index and eGFR levels. Results in italics indicate statistical significance at the 0.05 level
MANW metabolically abnormal, but normal weight, MAO metabolically abnormal obese, MHO metabolically healthy, but obese, MHNW metabolically healthy normal 
weight
MHNW MHO MANW MAO
Presence of plaque
 Crude 1 0.80 (0.55–1.16) 1.41 (0.84–2.35) 1.43 (0.99–2.06)
 Model 1 1 0.98 (0.65–1.46) 0.96 (0.55–1.68) 1.42 (1.01–2.00)
 Model 2 1 0.98 (0.65–1.47) 0.91 (0.51–1.61) 1.49 (1.03–2.16)
 Model 3 1 0.98 (0.64–1.48) 0.95 (0.53–1.70) 1.49 (1.02–2.16)
Plaque, moderate risk
 Prevalence (%) 10.8 12.0 15.0 15.4
 Crude 1 1.05 (0.63–1.73) 1.53 (0.76–3.09) 1.58 (0.99–2.53)
 Model 1 1 1.22 (0.72–2.04) 1.12 (0.54–2.31) 1.57 (0.97–2.54)
 Model 2 1 1.16 (0.68–1.97) 1.09 (0.51–2.33) 1.65 (1.01–2.68)
 Model 3 1 1.28 (0.74–2.20) 1.11 (0.50–2.44) 1.87 (1.11–3.14)
Plaque, high risk
 Prevalence (%) 15.8 10.4 18.8 18.6
 Crude 1 0.62 (0.38–1.02) 1.32 (0.69–2.49) 1.31 (0.86–1.99)
 Model 1 1 0.77 (0.45–1.30) 0.84 (0.42–1.67) 1.33 (0.84–2.09)
 Model 2 1 0.78 (0.45–1.34) 0.89 (0.44–1.80) 1.39 (0.87–2.19)
 Model 3 1 0.84 (0.48–1.45) 0.71 (0.33–1.50) 1.25 (0.76–2.07)







Fig. 2 Adjusted odds ratios and 95 % confidence intervals of carotid 
atherosclerosis according to obesity subtypes. *Reference, **p value 
<0.05. MHNW metabolically healthy normal weight, MHO metaboli‑
cally healthy, but obese, MANW metabolically abnormal, but normal 




























Fig. 3 Prevalence of metabolic syndrome according to obesity. 
Obesity was defined as a body mass index ≥25.0 kg/m2. MetS meta‑
bolic syndrome, MHNW metabolically healthy normal weight, MHO 
metabolically healthy, but obese, MANW metabolically abnormal, but 
normal weight, MAO metabolically abnormal obese
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lipodystrophy that is insufficient adipose tissue, especially 
subcutaneous depots, to carry out the normal buffering 
function of lipid flux and leads to the lipotoxicity which 
is an over-accumulation of triacylglycerol in abnormal 
sites such as skeletal muscle, liver and pancreas, and 
could be a causal factor of insulin resistance [30]. Addi-
tionally, MANW subtype showed higher concentrations 
of oxidized low-density lipoprotein and inflammatory 
cytokines such as tumor necrosis factor-α and interleu-
kin-6, compared with MHNW control [31], suggesting 
that MANW subtype could relate more to the presence 
or the developments of CVD/stroke events. MANW sub-
type is not rare with a prevalence of 3–28 % depending 
on the definition of it and the ethnicity. In this study, the 
prevalence of MANW subtype in Korean men was 8.2 % 
overall and 16.5 % among those with normal weight. In 
particular, Asian populations have higher prevalence 
rates of MANW subtype than Caucasian populations 
[32, 33], and the ethnic differences may be attributable to 
higher visceral adipose tissue at the same BMI levels in 
Asians compared to Caucasians [34].
However, in this study, in spite of multiple metabolic 
abnormalities such as elevated fasting glucose, triglyc-
erides, HOMA-IR index, and blood pressure, and low 
HDL-C in MANW subtype, there were no associations 
with carotid atherosclerosis compared to MHNW con-
trols. Because many participants with well-controlled 
diabetes or hypertension were included in MANW sub-
type of this study and the proper management to main-
tain good medical condition might contribute to these 
results, the interpretation of the results needs to be made 
with caution. Further prospective trials are necessary to 
more certainly settle this issue in the MANW subtype of 
Korean men.
Not surprisingly but importantly, MAO subtype as the 
concomitant presence of obesity and MetS showed a pos-
itive association with carotid atherosclerosis in Korean 
men, consistent with previous reports [35]. In this 
regard, the consideration for the presence of metabolic 
abnormalities may help to discriminate the high-risk 
obese status among Korean obese men for the prediction 
and prevention of CVD/stroke.
The strength of the present study was that as indica-
tors of subclinical atherosclerosis, not only CIMT, but 
also the presence and severity of carotid plaque were 
measured, and from these measurements, carotid ath-
erosclerosis was identified, and the associations between 
subtypes of obesity and the various predictors of CVD/
stroke events were examined. However, this study had 
several limitations. First, cross-sectional analysis can-
not be used to determine causal relationships. However, 
due to the lag time necessary for the transition from the 
presence of MetS or obesity to overt CVD/stroke events 
[24], the cross-sectional design would be more suitable 
for investigating the associations of subclinical athero-
sclerosis with the subtypes of obesity, rather than for 
evaluating the occurrence of overt CVD/stroke events 
according to the subtypes of obesity. Second, the con-
cept of “overweight (23.0 ≤ BMI < 25.0 kg/m2)” from the 
definition of “normal weight (BMI  <  25.0  kg/m2)” was 
not distinguished in this study. Third, we only included 
Korean men aged 19–80  years of age, therefore addi-
tional studies are needed to examine the associations of 
carotid atherosclerosis with obesity subtypes in Korean 
women.
Conclusions
In Korean men, mean CIMT in the MAO subtype of 
obesity was higher than that in MHNW controls. Only 
the MAO subtype showed positive associations with the 
presence of carotid plaque and carotid atherosclerosis, 
whereas MHO and MANW subtypes did not, compared 
to MHNW controls. Additional prospective studies are 
needed to evaluate preclinical carotid atherosclerosis 
according to the subtypes of obesity to establish effective 
strategies for preventing CVD/stroke events and predict-
ing the occurrence of CVD/stroke events according to 
obesity and metabolic abnormalities.
Table 4 Association between carotid atherosclerosis and metabolic syndrome according to obesity
Values are expressed as odds ratio (95 % confidence interval). Data were analysed with adjusting for age, smoking, alcohol consumption, physical activity, total 
cholesterol, LDL-C, HOMA-IR index and eGFR levels. Results in italics indicate statistical significance at the 0.05 level
CIMT carotid intima-media thickness, MANW metabolically abnormal, but normal weight, MAO metabolically abnormal obese, MHO metabolically healthy, but obese, 
MHNW metabolically healthy normal weight
Increased CIMT p value Plaque p value Carotid atherosclerosis p value
MHNW 1 1 – 1 –
MANW 0.74 (0.34–1.59) 0.443 0.59 (0.31–1.16) 0.127 0.70 (0.33–1.51) 0.364
MHO 1 1 – 1 –
MAO 1.80 (1.02–3.17) 0.041 1.66 (1.02–2.67) 0.039 1.69 (1.07–2.65) 0.023
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